The Delaware Supreme Court recently affirmed a decision from the Court of Chancery that held a poison pill with an unusually low trigger was a reasonable response to a specific threat to the corporation.
In Versata Enterprises Inc. v. Selectica Inc., the court also clarified the standard to be used when assessing poison pills, ruling that they are preclusive if they make success in a proxy contest “realistically unattainable.”
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
